Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometry.
about
Stable isotope-resolved metabolomics and applications for drug developmentMass spectrometry imaging of therapeutics from animal models to three-dimensional cell culturesFine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry.From pixel to voxel: a deeper view of biological tissue by 3D mass spectral imagingMALDI imaging mass spectrometry--painting molecular picturesMolecular morphology of the chick heart visualized by MALDI imaging mass spectrometry.MALDI tissue profiling of integral membrane proteins from ocular tissues.MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology.Biosynthetic origin of natural products isolated from marine microorganism-invertebrate assemblages.MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue.Imaging of lipids in spinal cord using intermediate pressure matrix-assisted laser desorption-linear ion trap/Orbitrap MSSimultaneous detection of intracellular target and off-target binding of small molecule cancer drugs at nanomolar concentrations.Imaging mass spectrometry for the assessment of drugs and metabolites in tissue.A quantitation method for mass spectrometry imaging.Matrix-assisted laser desorption mass spectrometry imaging for the examination of imipramine absorption by Straticell-RHE-EPI/001 an artificial model of the human epidermis.Distribution of chloroquine in ocular tissue of pigmented rat using matrix-assisted laser desorption/ionization imaging quadrupole time-of-flight tandem mass spectrometry.Imaging of intact tissue sections: moving beyond the microscopeMALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications.State-of-the-art MS technology applications in lung disease.Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q Exactive and comparison with LC-MS/MS SRM assay.Comprehensive identification of proteins from MALDI imaging.Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging.A critical evaluation of the current state-of-the-art in quantitative imaging mass spectrometry.Alternative two-step matrix application method for imaging mass spectrometry to avoid tissue shrinkage and improve ionization efficiency.Impact of drug administration route on drug delivery and distribution into the lung: an imaging mass spectrometry approach.Mass spectrometry imaging for drugs and metabolites.Advances in tissue section preparation for MALDI imaging MS.Quantification of Candesartan in Mouse Plasma by MALDI-TOFMS and in Tissue Sections by MALDI-Imaging Using the Stable-Isotope Dilution TechniqueQuantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionizationThe development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.Quantification in MALDI-MS imaging: what can we learn from MALDI-selected reaction monitoring and what can we expect for imaging?MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice.Assessing drug and metabolite detection in liver tissue by UV-MALDI and IR-MALDESI mass spectrometry imaging coupled to FT-ICR MS.Drug localizations in tissue by mass spectrometry imaging.Novel insights in drug metabolism by MS imaging.Recent Advances in Mass Spectrometry for the Identification of Neuro-chemicals and their Metabolites in BiofluidsTissue analysis by imaging MS.Qualitative and quantitative mass spectrometry imaging of drugs and metabolites in tissue at therapeutic levels.MALDI-MS drug analysis in biological samples: opportunities and challenges.Label-free imaging of drug distribution and metabolism in colon cancer cells by Raman microscopy.
P2860
Q24629149-6AA8036B-0524-4AF3-B4AA-C0CE5C26A0A8Q26820859-6D1B3448-3717-4B7F-835C-869FEB9B6A3AQ28474824-A456FD0E-425B-4F8C-ACAD-755D9B85048BQ30472475-D55AFC9F-0165-458B-A99C-4CEE79C202A9Q30472639-7810235F-C10C-42CC-BDD0-47B8AF8A0EA9Q30475540-66526204-93ED-41A7-84E3-C4904DDBBBB2Q30489353-21080D42-7D1F-4846-A2D6-F5804DABAE1EQ30493634-C591AF24-C418-467C-A1A0-8553E5D8975EQ33318189-BE3DB213-EAB6-41FA-8A72-C392CD2A6F50Q33344986-9664468B-F76E-43C3-A26B-D79EA7FD8CC3Q33502828-54E98B76-3E0B-4B8A-99FE-7BCBB0E30E23Q33621763-43972295-56C1-4A31-AF31-2EF01C224CE1Q33748869-311E520B-4D16-4334-B87E-F7E173B0E8ACQ33801243-349695E6-1270-47BB-A4CC-79CD26E7E62DQ33867975-2C344869-F3C1-48BF-A207-33E20D4F3E05Q33905554-79B9F204-12FC-4CB8-8E1B-66F4329E3DA1Q33919463-6A6F816C-0AFE-4116-B569-FFE8D08D6493Q33976656-F3F415A1-474D-4033-BB14-5D334E98CA7FQ34089332-630F5904-DEAE-4697-A7F0-5F302F5A696AQ34364249-2B946C0A-FDB5-4C02-8B57-78715451568BQ34778073-959BD7EA-37B8-43E8-B7B1-CD5308746F5BQ35007589-5773CB81-5BDB-4AB7-9970-7AA226911E20Q35054662-4DF4F5BE-E76B-4E90-923D-C0B5AA6CA020Q35066971-0FD83345-6573-4116-B767-6CA73623C88BQ35078907-AB6D188E-8BC0-45AA-8C80-434B73228948Q35151495-50F17851-6ACB-41C6-82F5-4CAE0ACD09ADQ35164791-9D63605B-7834-407D-BD70-5F091FB7982BQ35173871-E03038C2-865E-4B7B-B0EA-3079194AD479Q35334381-543E39E4-859C-4CD0-85EE-3CBD8C7B1AB5Q35419675-CFCB9F23-F29E-4A57-8395-7CC114E80FE5Q35500606-AFBCBF3E-4DF8-4D79-A774-120F92E89AE2Q35549222-432F9155-434B-45ED-94C7-182742568665Q35657674-CC06DC02-F27A-45ED-8F5E-D0DE5847B74EQ35761343-9596A326-04FF-4F82-A780-4DBAFDA5E38AQ35936145-5B541C4B-19C6-4460-84A2-7D23352CF6B7Q37098668-16C8A325-6341-443E-9A65-53D446F56059Q37970732-20ADA17E-A869-48C2-A001-C57788A4D9BCQ38123694-5219C7BB-4FB5-448C-BB98-2FB135B22535Q38831413-C0D1D256-55DA-4D96-B2D0-319B4C58699AQ39034201-7C2BA93A-659F-4791-821A-F178522245A7
P2860
Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometry.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@ast
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@en
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@nl
type
label
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@ast
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@en
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@nl
prefLabel
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@ast
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@en
Analysis of erlotinib and its ...... e-of-flight mass spectrometry.
@nl
P2093
P356
P1476
Analysis of erlotinib and its ...... me-of-flight mass spectrometry
@en
P2093
Emmanuel Varesio
Gérard Hopfgartner
Luca Signor
Roland F Staack
Volkmar Starke
P304
P356
10.1002/JMS.1225
P577
2007-07-01T00:00:00Z